Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of N6AMT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1362.93 | 245 / 245 | 100% | 9.33 | 502 / 502 |
breast | 100% | 894.73 | 459 / 459 | 100% | 12.24 | 1116 / 1118 |
thymus | 100% | 1582.05 | 653 / 653 | 100% | 8.25 | 602 / 605 |
bladder | 100% | 1167.43 | 21 / 21 | 99% | 6.98 | 498 / 504 |
adrenal gland | 100% | 1271.26 | 258 / 258 | 99% | 10.82 | 227 / 230 |
kidney | 100% | 1058.35 | 89 / 89 | 99% | 7.76 | 888 / 901 |
uterus | 100% | 1905.68 | 170 / 170 | 98% | 6.52 | 451 / 459 |
intestine | 100% | 933.74 | 965 / 966 | 98% | 6.09 | 517 / 527 |
brain | 99% | 785.30 | 2623 / 2642 | 98% | 12.16 | 694 / 705 |
ovary | 100% | 2038.89 | 180 / 180 | 97% | 6.13 | 417 / 430 |
stomach | 99% | 739.52 | 355 / 359 | 98% | 5.56 | 279 / 286 |
pancreas | 98% | 458.57 | 320 / 328 | 99% | 6.68 | 176 / 178 |
lung | 98% | 723.42 | 568 / 578 | 98% | 6.02 | 1129 / 1155 |
esophagus | 100% | 1052.20 | 1441 / 1445 | 93% | 3.97 | 171 / 183 |
skin | 97% | 638.82 | 1746 / 1809 | 97% | 8.28 | 456 / 472 |
liver | 96% | 428.72 | 217 / 226 | 90% | 4.04 | 364 / 406 |
spleen | 100% | 1023.67 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.76 | 1 / 1 |
blood vessel | 100% | 1230.08 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 754.65 | 1196 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 813.56 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 4.19 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 5.00 | 28 / 29 |
muscle | 96% | 532.51 | 773 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 6.74 | 72 / 80 |
peripheral blood | 28% | 200.78 | 262 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0032259 | Biological process | methylation |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0018364 | Biological process | peptidyl-glutamine methylation |
GO_0009404 | Biological process | toxin metabolic process |
GO_0018872 | Biological process | arsonoacetate metabolic process |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0035657 | Cellular component | eRF1 methyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0003676 | Molecular function | nucleic acid binding |
GO_1904047 | Molecular function | S-adenosyl-L-methionine binding |
GO_0009007 | Molecular function | site-specific DNA-methyltransferase (adenine-specific) activity |
GO_0140984 | Molecular function | histone H4K12 methyltransferase activity |
GO_0036009 | Molecular function | protein-glutamine N-methyltransferase activity |
GO_0008276 | Molecular function | protein methyltransferase activity |
GO_0030791 | Molecular function | arsenite methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
Gene name | N6AMT1 |
Protein name | Methyltransferase N6AMT1 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-) |
Synonyms | PRED28 KMT9 HEMK2 C21orf127 |
Description | FUNCTION: Methyltransferase that can methylate proteins and, to a lower extent, arsenic . Catalytic subunit of a heterodimer with TRMT112, which monomethylates 'Lys-12' of histone H4 (H4K12me1), a modification present at the promoters of numerous genes encoding cell cycle regulators . Catalytic subunit of a heterodimer with TRMT112, which catalyzes N5-methylation of Glu residue of proteins with a Gly-Gln-Xaa-Xaa-Xaa-Arg motif . Methylates ETF1 on 'Gln-185'; ETF1 needs to be complexed to ERF3 in its GTP-bound form to be efficiently methylated . May also play a role in the modulation of arsenic-induced toxicity by mediating the conversion of monomethylarsonous acid (3+) into the less toxic dimethylarsonic acid . It however only plays a limited role in arsenic metabolism compared with AS3MT . . |
Accessions | ENST00000303775.10 [Q9Y5N5-1] Q9Y5N5 ENST00000351429.7 [Q9Y5N5-2] ENST00000460212.1 [Q9Y5N5-1] |